# Cerus Corporation (CERS)

Source: https://www.quantisnow.com/company/CERS
Generated: 2026-11-21T09:38:26.463Z

- Ticker: CERS
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 1997
- SEC CIK: 0001020214
- Website: cerus.com

## About

Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation has collaboration with LifeSouth Community Blood Centers to manufacture INTERCEPT Fibrinogen Complex. The company was incorporated in 1991 and is headquartered in Concord, California.

## Latest CERS news and filings

- 2026-11-17 21:01 UTC [Conference Announcement] [Cerus Corporation to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/cerus-corporation-to-participate-in-upcoming-investor-conferences-6796478)
- 2026-11-13 17:41 UTC [SEC Schedule 13G] [Amendment: SEC Form SCHEDULE 13G/A filed by Cerus Corporation](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-cerus-corporation-6789998)
- 2026-11-11 13:30 UTC [Conference Announcement] [Cerus Corporation to Participate in the 17th Annual Craig-Hallum Alpha Select Conference](https://www.quantisnow.com/insight/cerus-corporation-to-participate-in-the-17th-annual-craig-hallum-alpha-6785285)
- 2026-11-02 22:06 UTC [SEC Form S-3] [SEC Form S-3 filed by Cerus Corporation](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-cerus-corporation-6767820)
- 2026-11-02 21:19 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Cerus Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cerus-corporation-6767340)
- 2026-11-02 21:07 UTC [SEC Form 8-K] [Cerus Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cerus-corporation-filed-sec-form-8-k-results-of-operations-and-6767120)
- 2026-11-02 21:05 UTC [Earnings] [Cerus Corporation Announces Third Quarter 2026 Financial Results](https://www.quantisnow.com/insight/cerus-corporation-announces-third-quarter-2026-financial-results-6767032)
- 2026-11-02 21:00 UTC [Earnings Date] [Cerus Corporation Announces Positive Topline Results from Phase 3 RedeS Trial of the INTERCEPT Blood System for Red Blood Cells](https://www.quantisnow.com/insight/cerus-corporation-announces-positive-topline-results-from-phase-3-redes-6766908)
- 2026-10-19 20:01 UTC [Earnings Date] [Cerus Corporation to Release Third Quarter 2026 Financial Results on November 2, 2026](https://www.quantisnow.com/insight/cerus-corporation-to-release-third-quarter-2026-financial-results-on-6750472)
- 2026-10-14 20:30 UTC [Cerus Corporation Announces Workshop and Abstracts at the 2026 AABB Annual Meeting](https://www.quantisnow.com/insight/cerus-corporation-announces-workshop-and-abstracts-at-the-2026-aabb-6746722)
- 2026-08-18 00:18 UTC [SEC Form 4] [Chief Legal Officer Jensen Chrystal sold $89,529 worth of shares (30,000 units at $2.98) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 936,657 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-legal-officer-jensen-chrystal-sold-89529-worth-of-shares-6685651)
- 2026-07-30 21:28 UTC [SEC Form S-8] [SEC Form S-8 filed by Cerus Corporation](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-cerus-corporation-6656668)
- 2026-07-30 20:44 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Cerus Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cerus-corporation-6656500)
- 2026-07-30 20:03 UTC [SEC Form 8-K] [Cerus Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cerus-corporation-filed-sec-form-8-k-results-of-operations-and-6656029)
- 2026-07-30 20:01 UTC [Earnings Date] [Cerus Corporation Announces Second Quarter 2026 Financial Results](https://www.quantisnow.com/insight/cerus-corporation-announces-second-quarter-2026-financial-results-6655877)
- 2026-07-20 21:03 UTC [SEC Form 4] [Chief Executive Officer Jayaraman Vivek K sold $52,665 worth of shares (16,666 units at $3.16) as part of a pre-agreed trading plan, decreasing direct ownership by 0.74% to 2,232,211 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-jayaraman-vivek-k-sold-52665-worth-of-6642722)
- 2026-07-16 20:01 UTC [Earnings Date] [Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026](https://www.quantisnow.com/insight/cerus-corporation-to-release-second-quarter-2026-financial-results-on-6639570)
- 2026-07-10 20:35 UTC [SEC Form 8-K] [Cerus Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cerus-corporation-filed-sec-form-8-k-leadership-update-financial-statements-6634294)
- 2026-07-02 23:19 UTC [SEC Form 4] [Chief Financial Officer Green Kevin Dennis sold $99,105 worth of shares (33,676 units at $2.94) as part of a pre-agreed trading plan and gave a grant of 63,600 shares, decreasing direct ownership by 8% to 1,062,188 units (SEC Form 4) to cover withholding tax](https://www.quantisnow.com/insight/chief-financial-officer-green-kevin-dennis-sold-99105-worth-of-6626831)
- 2026-07-02 23:18 UTC [SEC Form 4] [Chief Operating Officer Jayaraman Vivek K was granted 554,529 shares, gave a grant of 80,000 shares and sold $124,658 worth of shares (42,359 units at $2.94) as part of a pre-agreed trading plan, increasing direct ownership by 24% to 2,248,877 units (SEC Form 4) to satisfy withholding obligation](https://www.quantisnow.com/insight/chief-operating-officer-jayaraman-vivek-k-was-granted-554529-shares-6626827)
- 2026-07-02 23:15 UTC [SEC Form 4] [Chief Legal Officer Jensen Chrystal gave a grant of 55,000 shares and sold $71,598 worth of shares (24,329 units at $2.94) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 966,657 units (SEC Form 4) (for withholding tax)](https://www.quantisnow.com/insight/chief-legal-officer-jensen-chrystal-gave-a-grant-of-55000-6626825)
- 2026-07-02 23:13 UTC [SEC Form 4] [President and CEO Greenman William Mariner gave a grant of 192,500 shares and sold $299,937 worth of shares (101,919 units at $2.94) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 5,053,036 units (SEC Form 4) to cover taxes](https://www.quantisnow.com/insight/president-and-ceo-greenman-william-mariner-gave-a-grant-of-6626824)
- 2026-06-17 12:30 UTC [Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress](https://www.quantisnow.com/insight/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-6606004)
- 2026-06-12 01:17 UTC [SEC Form 4] [Director Bjerkholt Eric sold $53,180 worth of shares (20,454 units at $2.60), decreasing direct ownership by 7% to 261,679 units (SEC Form 4)](https://www.quantisnow.com/insight/director-bjerkholt-eric-sold-53180-worth-of-shares-20454-units-6599373)
- 2026-06-08 20:20 UTC [SEC Form 8-K] [Cerus Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation](https://www.quantisnow.com/insight/cerus-corporation-filed-sec-form-8-k-entry-into-a-material-6593532)
- 2026-06-08 12:30 UTC [Cerus Corporation Closes New Debt Facility of Up to $110 Million](https://www.quantisnow.com/insight/cerus-corporation-closes-new-debt-facility-of-up-to-110-6592692)
- 2026-06-03 20:17 UTC [SEC Form 8-K] [Cerus Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/cerus-corporation-filed-sec-form-8-k-leadership-update-submission-of-6586973)
- 2026-06-02 23:59 UTC [SEC Form 4] [Director Lucena Ann was granted 60,000 shares, increasing direct ownership by 35% to 232,284 units (SEC Form 4)](https://www.quantisnow.com/insight/director-lucena-ann-was-granted-60000-shares-increasing-direct-ownership-6585441)
- 2026-06-02 23:54 UTC [SEC Form 4] [Director Bjerkholt Eric was granted 60,000 shares, increasing direct ownership by 27% to 282,133 units (SEC Form 4)](https://www.quantisnow.com/insight/director-bjerkholt-eric-was-granted-60000-shares-increasing-direct-ownership-6585431)
- 2026-06-02 23:50 UTC [SEC Form 4] [Director Nachtsheim Jami K was granted 60,000 shares, increasing direct ownership by 29% to 268,362 units (SEC Form 4)](https://www.quantisnow.com/insight/director-nachtsheim-jami-k-was-granted-60000-shares-increasing-direct-6585423)
- 2026-06-02 23:46 UTC [SEC Form 4] [Chief Operating Officer Jayaraman Vivek K sold $50,001 worth of shares (16,667 units at $3.00) as part of a pre-agreed trading plan, decreasing direct ownership by 1.00% to 1,656,707 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-operating-officer-jayaraman-vivek-k-sold-50001-worth-of-6585418)
- 2026-06-02 23:37 UTC [SEC Form 4] [Director Witney Frank was granted 60,000 shares, increasing direct ownership by 21% to 340,059 units (SEC Form 4)](https://www.quantisnow.com/insight/director-witney-frank-was-granted-60000-shares-increasing-direct-ownership-6585397)
- 2026-06-02 23:35 UTC [SEC Form 4] [Director Gregory Dean A. was granted 60,000 shares, increasing direct ownership by 69% to 146,725 units (SEC Form 4)](https://www.quantisnow.com/insight/director-gregory-dean-a-was-granted-60000-shares-increasing-direct-6585392)
- 2026-06-02 23:33 UTC [SEC Form 4] [Director Shan Hua was granted 60,000 shares, increasing direct ownership by 45% to 192,386 units (SEC Form 4)](https://www.quantisnow.com/insight/director-shan-hua-was-granted-60000-shares-increasing-direct-ownership-6585391)
- 2026-05-29 20:15 UTC [SEC Form SD filed by Cerus Corporation](https://www.quantisnow.com/insight/sec-form-sd-filed-by-cerus-corporation-6579273)
- 2026-05-27 15:35 UTC [Bradley L. Radoff Announces Intent to Withhold Votes from Chair and CEO William Greenman and Director Ann Lucena](https://www.quantisnow.com/insight/bradley-l-radoff-announces-intent-to-withhold-votes-from-chair-6574304)
- 2026-05-05 22:31 UTC [SEC Form 4] [Chief Operating Officer Jayaraman Vivek K sold $50,001 worth of shares (16,667 units at $3.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.99% to 1,673,374 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-operating-officer-jayaraman-vivek-k-sold-50001-worth-of-6533423)
- 2026-05-01 20:07 UTC [SEC Form 144] [SEC Form 144 filed by Cerus Corporation](https://www.quantisnow.com/insight/sec-form-144-filed-by-cerus-corporation-6526770)
- 2026-05-01 11:46 UTC [Analyst Upgrade] [Cerus upgraded by BTIG Research with a new price target](https://www.quantisnow.com/insight/cerus-upgraded-by-btig-research-with-a-new-price-target-6525942)
- 2026-04-30 21:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Cerus Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cerus-corporation-6525368)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CERS
- Earnings history: https://www.quantisnow.com/earnings/CERS
- Dividend history: https://www.quantisnow.com/dividends/CERS
- Insider transactions: https://www.quantisnow.com/insiders/CERS
- Options chain: https://www.quantisnow.com/options/CERS
- SEC 8-K filings only: https://www.quantisnow.com/company/CERS/8-k
- RSS and alerts for CERS: https://www.quantisnow.com/docs/rss-feeds.md
